Dr. Barry Katzen, a pioneering figure in interventional radiology, shares his remarkable journey from training during the field's inception to founding the Miami Cardiac and Vascular Institute. He discusses the early challenges and skepticism surrounding IR, highlighting the importance of innovation over complacency. Dr. Katzen emphasizes the value of patient-centered care and mentorship, urging future interventional radiologists to remain dedicated to evolving practices for better outcomes. His insights encapsulate the transformative spirit that continues to shape the field.

Is social media an effective patient acquisition tool for interventional radiologists? In a word: absolutely. Learn how to reach more patients in this week’s BackTable Podcast, where Dr. Gustavo Elias joins Dr. Ally Baheti to discuss the benefits he has seen with social media, and the content strategies that he uses in his medical practice.---SYNPOSISThe episode begins with Dr. Elias sharing his journey of overcoming initial reservations around posting content. The doctors emphasize the importance of individuality and passion in showing what IR can offer to the public in easily-digestible ways. Dr. Elias then discusses the impact of social media on patient engagement, and shares practical tips for physicians who are looking to enhance their online presence. Dr. Elias also touches on optimal posting schedules, collaboration tips, and balancing professionalism with approachability.---TIMESTAMPS00:00 - Introduction04:02 - Social Media for Interventional Radiologists08:56 - Building a Social Media Presence19:24 - Optimal Posting Strategies21:58 - Collaborations and Platforms25:27 - Conclusion

This week, Dr. Asad Baig, an interventional radiologist from Columbia University, dives into the world of microwave liver ablation. He shares innovative techniques and the importance of personalizing treatment based on patient needs. Dr. Baig discusses how real-time visualization software enhances ablation accuracy and emphasizes the critical role of teamwork in tumor boards. The conversation also covers best practices for tackling challenging tumors, ensuring patient safety, and fostering effective communication with patients throughout their care.

Dr. Clifford Weiss, the Director of the Johns Hopkins Vascular Anomalies Center, shares his expertise on hereditary hemorrhagic telangiectasia (HHT) and pulmonary AVMs. He discusses the critical role of early diagnosis and multidisciplinary teams in effective patient care. The conversation highlights evolving guidelines for intervention, the intricacies of embolization techniques, and the importance of genetic testing. Dr. Weiss also sheds light on innovative treatments and ongoing challenges in managing HHT, showcasing the impact of specialized care on patient outcomes.

Teleradiology, artificial intelligence, and private equity takeovers—how do we navigate these rapid changes in the radiology landscape? In this episode, our co-hosts Dr. Ally Baheti and Dr. Mike Barraza bring Dr. Ben White back to the show to provide an update on the current radiology job market and share his insights on reclaiming value for the profession. Dr. White begins by reflecting on the changes since his last appearance with us in 2022, focusing primarily on the ongoing shortage of radiologists, which has lasted longer than anticipated during the pandemic, and the explosion of teleradiology.---SYNPOSISToday’s radiologists are more mobile than ever, with remote work options and the appeal of sensationalized job postings. Dr. White also discusses the instability of more established practices, particularly when legacy partners depart after fulfilling their contractual obligations. In response, many practices are refinancing their debt, which has led to a decrease in practice acquisitions.Dr. White believes that large-scale healthcare operations often result in increased inefficiency and reduced agility. The downstream effects include the commoditization of teleradiologists, concerns about decreased quality of reads, a limited scope of practice for procedures, reduced access to imaging for smaller hospitals, longer wait times, and more unstable locum staffing. The doctors also speculate about the future division of radiology into different service tiers, depending on the level of access each hospital has to radiologists.Finally, Dr. White highlights his Independent Radiology job board, which lists open positions from physician-owned practices. His goal in creating the website is to address the pain points of other job advertisement sites, where misleading postings are common. He wants radiologists to consider joining a team of physicians, rather than simply accepting a job. His advice to all radiologists is to expect uncertainty in the job market and to remain flexible.---TIMESTAMPS00:00 - Current Radiology Job Market07:43 - Updates on Private Equity in Radiology16:26 - Role of Artificial Intelligence22:46 - Growing Imaging Volume and Efficiency26:51 - Challenges in Radiology Staffing36:49 - Independent Radiology Job Board50:07 - Future of Radiology and Final Thoughts---RESOURCESBackTable VI Ep. 277- Private Equity and the Radiology Job Environment with Dr. Ben White:https://www.backtable.com/shows/vi/podcasts/277/private-equity-the-radiology-job-environmentIndependent Radiology Job Board:https://www.independentradiology.com/

Join Dr. Adam Burgoyne, a medical oncologist; Siddharth Padia, an interventional radiologist; and Gabriel Schnickel, a transplant and hepatobiliary surgeon, as they dissect complex hepatocellular carcinoma (HCC) cases. They explore treatment options like surgical resection, thermal ablation, and systemic therapies while emphasizing a collaborative approach. The discussion highlights innovative treatment strategies, including immunotherapy and the evolving transplant criteria for patients with portal vein thrombosis. Tune in for a deep dive into the intricate world of HCC management!

Dr. Robert Martin, Director of Surgical Oncology at the University of Louisville, is a trailblazer in liver-directed therapies and minimally invasive procedures. He shares insights on the importance of collaboration among oncology specialties for optimal patient care. The conversation dives into the evolution of liver cancer treatments and emerging clinical trials, highlighting innovative techniques like microwave ablation and irreversible electroporation. Dr. Martin emphasizes the need for a growth mindset and lifelong learning among young professionals in the field.

Dr. Siddarth Padia, Dr. Tyler Sandow, Dr. Kavi Krishnasamy, and Dr. Kevin Burns share their journeys in interventional oncology, exploring how they transitioned from general radiology to specializing in liver cancer. They discuss innovative telehealth solutions and hybrid care models that enhance patient access and communication. The doctors emphasize the importance of clinic support and how integrating advanced technologies can drive procedural growth. Finally, they highlight the role of mentorship and relationship-building in overcoming challenges in establishing successful practices.

In this enlightening discussion, Dr. Altan Ahmed from Moffitt Cancer Center and Dr. Sid Padia from UCLA delve into the innovative HEPZATO treatment for liver metastases from uveal melanoma. They explore patient selection for clinical trials and the intricacies of the treatment procedure. The conversation highlights the importance of teamwork in optimizing workflow and drug dosing, as well as the need for ongoing research to address current gaps. They also discuss future applications for HEPZATO in treating other malignancies, promising new hope for patients.

Dr. Siddharth Padia, an interventional radiologist at UCLA, and Dr. John Seal, a transplant and hepatobiliary surgeon at Ochsner Clinic, dive deep into the complexities of hepatocellular carcinoma treatment. They discuss the delicate balance between surgical resection and liver transplantation, influenced by factors like liver health and patient condition. The conversation highlights advancements in living donor transplantation and crucial communication about treatment expectations, all while navigating challenges like organ availability and evolving surgical techniques.